Compare NXT & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NXT | FMS |
|---|---|---|
| Founded | 2013 | 1996 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Semiconductors | Misc Health and Biotechnology Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.6B | 14.1B |
| IPO Year | 2023 | 1996 |
| Metric | NXT | FMS |
|---|---|---|
| Price | $87.17 | $23.77 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 21 | 2 |
| Target Price | ★ $91.80 | $30.00 |
| AVG Volume (30 Days) | ★ 2.2M | 535.7K |
| Earning Date | 10-23-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 2.40% |
| EPS Growth | N/A | ★ 8.62 |
| EPS | ★ 3.85 | 2.86 |
| Revenue | $3,373,226,000.00 | ★ $23,046,819,198.00 |
| Revenue This Year | $17.63 | $2.12 |
| Revenue Next Year | $11.43 | $2.92 |
| P/E Ratio | $22.69 | ★ $16.11 |
| Revenue Growth | ★ 20.37 | 2.10 |
| 52 Week Low | $33.29 | $22.05 |
| 52 Week High | $112.74 | $30.46 |
| Indicator | NXT | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 44.12 | 42.43 |
| Support Level | $84.02 | $22.51 |
| Resistance Level | $92.00 | $24.20 |
| Average True Range (ATR) | 6.16 | 0.28 |
| MACD | -1.19 | 0.13 |
| Stochastic Oscillator | 17.52 | 73.96 |
Nextracker (and its subsidiaries) is a leading provider of intelligent, integrated solar tracker and software solutions used in utility-scale and distributed generation solar projects around the world. Nextracker's products enable solar panels in utility-scale power plants to follow the sun's movement across the sky and optimize plant performance. Nextracker has operations in the United States, Mexico, Spain and other countries in Europe, India, Australia, the Middle East, Africa, and Brazil.
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.